These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intranasal versus transdermal matrix oestrogen replacement in Australasian women. Davis SR; Davison SL; Wilson S; Shepherd J; Lawton B Maturitas; 2005 Jun; 51(2):163-71. PubMed ID: 15917157 [TBL] [Abstract][Full Text] [Related]
7. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Balfour JA; Heel RC Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514 [TBL] [Abstract][Full Text] [Related]
8. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause]. Rachev E Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531 [TBL] [Abstract][Full Text] [Related]
9. Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Br J Clin Pharmacol 1998 Feb; 45 (2): 170-172. Kneer-Aronoff C J Womens Health; 1998 Oct; 7(8):1054-5. PubMed ID: 10026007 [No Abstract] [Full Text] [Related]
10. [Systemic sensitization to 17-beta estradiol induced by transcutaneous administration]. El Sayed F; Bayle-Lebey P; Marguery MC; Bazex J Ann Dermatol Venereol; 1996; 123(1):26-8. PubMed ID: 8734113 [TBL] [Abstract][Full Text] [Related]
11. Intranasal estradiol: new formulation. Intranasal oestrogen delivery system: just a gimmick. Prescrire Int; 2002 Dec; 11(62):163-5. PubMed ID: 12469692 [TBL] [Abstract][Full Text] [Related]
12. Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol. Matsui S; Yasui T; Kasai K; Keyama K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M J Obstet Gynaecol; 2017 Jul; 37(5):627-632. PubMed ID: 28317410 [TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch. Liang R; Wong RW; Cheng IK Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965 [No Abstract] [Full Text] [Related]
14. Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit? Ockrim JL; Lalani el-N; Aslam M; Standfield N; Abel PD BJU Int; 2006 Mar; 97(3):498-504. PubMed ID: 16469015 [TBL] [Abstract][Full Text] [Related]
15. Effects of high dose oestrogen therapy on circulating inflammatory markers. Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116 [TBL] [Abstract][Full Text] [Related]
16. [Oestrogel--a transdermal and convenient method of hormone replacement therapy]. Krumov G Akush Ginekol (Sofiia); 2003; 42 Suppl 1():17-20. PubMed ID: 12858498 [No Abstract] [Full Text] [Related]